// App-Quantinova.ai

692 : Evaluating transfer of certolizumab pegol into breast milk: results from a prospective, postmarketing, multicenter pharmacokinetic study

Researchers

Presenter

  • John Thorp

Principal Investigators

  • Megan E.B. Clowse

  • Frauke Frger

  • Caroline Hwang

  • Radboud J.E.M. Dolhain

  • Astrid van Tubergen

  • Laura Shaughnessy

  • Jeff Simpson

  • Marie Teil

  • Nathalie Toublanc

  • Maggie Wang

  • Thomas W. Hale

Medical Centers

  • University of North Carolina, Chapel Hill, NC

  • Duke University Medical Center, Durham, NC

  • University of Bern, Bern, Switzerland

  • Keck Hospital of USC, Los Angeles, CA

  • Universitair Medisch Centrum Rotterdam, Rotterdam, Netherlands

  • Maastricht University Medical Center, Maastricht, Netherlands

  • UCB Pharma, Raleigh, NC

  • UCB Pharma, Slough, UK Slough United Kingdom

  • UCB Pharma, Brussels, Belgium

  • Texas Tech University School of Medicine, Lubbock, TX

Locations

  • United States

  • Switzerland

  • Netherlands

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Certolizumab pegol

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved